Intratumor Heterogeneity Predicts Prognosis in Lepidic Predominant Lung Adenocarcinoma

作者
Benedikt Niedermaier,Michael Allgäuer,Thomas Muley,Marc Andre Schneider,Martin Eichhorn,Hauke Winter,Laura Valentina Klotz
出处
期刊:Thoracic Cancer [Wiley]
卷期号:16 (1): e15536-e15536 被引量:5
标识
DOI:10.1111/1759-7714.15536
摘要

OBJECTIVE: Among the different subtypes of invasive lung adenocarcinoma, lepidic predominant adenocarcinoma (LPA) has been recognized as the lowest-risk subtype with good prognosis. The aim of this study is to provide insight into the heterogeneity within LPA tumors and to better understand the influence of other sub-histologies on survival outcome. METHODS: Overall, 75 consecutive patients with LPA in pathologic stage I (TNM 8th edition) who underwent resection between 2010 and 2022 were included into this retrospective, single center analysis. The proportions of different growth patterns were reported in 5% increments according to the WHO classification. RESULTS: All tumors exhibited a predominantly lepidic growth pattern (median proportion 70%, IQR 60%-85%). The invasive component included acinar (n = 66, 88%), papillary (n = 41, 55%), micropapillary (n = 14, 19%), and solid growth patterns (n = 4, 5%), with most tumors exhibiting more than one invasive growth pattern. The presence of high-risk growth, that is, micropapillary and solid, was associated with higher T stage (r = 0.423, p = 0.0002). A classification of patients as lepidic/high-risk or lepidic/low-risk based on the presence of micropapillary and solid growth patterns resulted in a significantly worse disease-free survival (p = 0.0169, 5-year DFS: lepidic/high-risk 73% vs. lepidic/low-risk: 95%) for the lepidic/high-risk group, while the groups did not differ in age, gender, smoking status, or extent of resection. CONCLUSION: Patients with stage I LPA exhibit considerable intratumor heterogeneity regarding growth patterns, which can be used for prognostic stratification. The occurrence of micropapillary and solid growth patterns in LPA is associated with poorer disease-free survival.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
小马哥很开心完成签到,获得积分10
2秒前
2秒前
2秒前
晚风发布了新的文献求助20
2秒前
2秒前
2秒前
zhoujiangtao发布了新的文献求助50
3秒前
学术雷锋的应助被杨yang采纳,获得10
3秒前
an完成签到,获得积分10
3秒前
oldtiger完成签到,获得积分10
3秒前
艾小橙子完成签到,获得积分10
4秒前
jimmyyyyyy发布了新的文献求助10
4秒前
4秒前
有风完成签到,获得积分10
5秒前
LiuJiateng发布了新的文献求助10
5秒前
6秒前
小胖熊完成签到,获得积分10
6秒前
ruuu发布了新的文献求助10
6秒前
6秒前
璇璇完成签到,获得积分10
7秒前
dui发布了新的文献求助10
7秒前
现代的芹完成签到,获得积分10
7秒前
janie发布了新的文献求助10
8秒前
8秒前
一这那西发布了新的文献求助30
8秒前
orixero的应助被薄荷采纳,获得10
8秒前
禹平露完成签到,获得积分10
9秒前
Bluesky发布了新的文献求助10
9秒前
钟少完成签到 ,获得积分10
10秒前
10秒前
10秒前
10秒前
11秒前
11秒前
简单发布了新的文献求助10
11秒前
11秒前
LLH发布了新的文献求助10
11秒前
鲤鱼发布了新的文献求助10
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Mathematical models in hydrology 1000
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Butadiene hydroxytelechelic oligomers PBHT 500
Ecotourism 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8081016
求助须知:如何正确求助?哪些是违规求助? 9497173
关于积分的说明 21399244
捐赠科研通 7649241
什么是DOI,文献DOI怎么找? 3401538
关于科研通互助平台的介绍 2530665
邀请新用户注册赠送积分活动 2440209